A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

Clinical trial NCT05712278 · TERMINATED

Trial details

NCT number: NCT05712278
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia

Start date: 2023-06-16
Primary completion: 2024-02-23
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.